Net Prescription Drug Prices And Spending In Medicare Part D Before And After Generic Entry.

Authors

Scott Laughery, Colin Baker, Rachel Fehr

Published in

Health affairs (Project Hope). Volume 45. Issue 10. Pages 1112-1116.

Abstract

Generic competition lowers retail prescription drug prices, but little is known about its effect on net prices, accounting for manufacturer rebates. Using data on rebates and discounts for Part D, we estimated net prices, prescription volume, and spending before and after generic entry. Total spending fell as generics captured market share, even as total volume rose. Brand-name prices rose in a shrinking segment.

PMID:
42832723
Bibliographic data and abstract were imported from PubMed on 06 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.